Seretide

TargetMol
Product Code: TAR-TP2406
Supplier: TargetMol
CodeSizePrice
TAR-TP2406-10mg10mg£446.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Seretide, a combination of fluticasone and salmeterol, controls symptoms of asthma and chronic obstructive pulmonary disease (COPD).
CAS:
136112-01-1
Formula:
C50H68F3NO9S
Molecular Weight:
916.15
Purity:
0.98
SMILES:
OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1.CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@]12C)C(=O)SCF

References

Gao J, Pleasants RA. Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD. Int J Chron Obstruct Pulmon Dis. 2015 Apr 15;10:775-89. doi: 10.2147/COPD.S80656. eCollection 2015. Review. PubMed PMID: 25926729; PubMed Central PMCID: PMC4403740. Roberts MH, Borrego ME, Kharat AA, Marshik PL, Mapel DW. Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies. Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):167-92. doi: 10.1586/14737167.2016.1148602. Epub 2016 Feb 22. Review. PubMed PMID: 26839089. Rennard SI, Drummond MB. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet. 2015 May 2;385(9979):1778-1788. doi: 10.1016/S0140-6736(15)60647-X. Review. PubMed PMID: 25943942; PubMed Central PMCID: PMC4819246. Tricco AC, Strifler L, Veroniki AA, Yazdi F, Khan PA, Scott A, Ng C, Antony J, Mrklas K, D'Souza J, Cardoso R, Straus SE. Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis. BMJ Open. 2015 Oct 26;5(10):e009183. doi: 10.1136/bmjopen-2015-009183. Review. PubMed PMID: 26503392; PubMed Central PMCID: PMC4636655.